| 000 | 01386 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250517182616.0 | ||
| 264 | 0 | _c20180301 | |
| 008 | 201803s 0 0 eng d | ||
| 022 | _a1751-2441 | ||
| 024 | 7 |
_a10.1080/17512433.2018.1398644 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSuttorp, Meinolf | |
| 245 | 0 | 0 |
_aPharmacology and pharmacokinetics of imatinib in pediatric patients. _h[electronic resource] |
| 260 |
_bExpert review of clinical pharmacology _cMar 2018 |
||
| 300 |
_a219-231 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacokinetics |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aDrug Monitoring |
| 650 | 0 | 4 | _aFood-Drug Interactions |
| 650 | 0 | 4 | _aFusion Proteins, bcr-abl |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImatinib Mesylate _xpharmacokinetics |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy |
| 650 | 0 | 4 | _aMedication Adherence |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacokinetics |
| 700 | 1 | _aBornhäuser, Martin | |
| 700 | 1 | _aMetzler, Markus | |
| 700 | 1 | _aMillot, Frédéric | |
| 700 | 1 | _aSchleyer, Eberhard | |
| 773 | 0 |
_tExpert review of clinical pharmacology _gvol. 11 _gno. 3 _gp. 219-231 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/17512433.2018.1398644 _zAvailable from publisher's website |
| 999 |
_c27728133 _d27728133 |
||